Search

everythinglearnresearchcommunity

for

Search:↓

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Suppressing ODC activity reduces tumor growth in hair follicles.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

COX-2 levels change during the hair cycle and affect skin and hair growth.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Different forms of finasteride dissolve and remain stable differently, affecting capsule quality.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

1 alpha,25-dihydroxy-vitamin D3 and calcipotriol speed up cell differentiation in hair follicles.

A new compound, BOI, can help hair grow by changing hair cycle phases and increasing certain cell contents.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

A new compound effectively inhibits human 5α-reductase 1.

The new compound may be a safer alternative to finasteride for prostate protection.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

ODC overexpression in hair cells increases tumor growth by reducing Notch signaling.

KRT2.13 gene is similar to KRT2.9 but not expressed in hair follicles.

A new enzyme in rats may help regulate hair growth.

Compound 15a was effective in inhibiting 5α-reductase.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Using K2S2O8 as an oxidizing agent in a specific condition, we can make Finasteride with 96.3% yield and 99.6% purity. This method is also good for other compounds and is environmentally friendly.